Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.740
-0.110 (-3.86%)
At close: Aug 1, 2025, 4:00 PM
2.740
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:00 PM EDT

Alaunos Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Alaunos Therapeutics.

Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

There are currently no analyst ratings available for Alaunos Therapeutics.

Recommendation Trends

RatingMar '23Apr '23May '23Jun '23Jul '23Aug '23
Strong Buy001110
Buy333330
Hold000000
Sell000000
Strong Sell000000
Total334440

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 16, 2023
Laidlaw & Co.
Laidlaw & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 15, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Upgrades
$225
Strong BuyUpgrades$225+8,111.68%May 15, 2023
Wells Fargo
Wells Fargo
Buy
Initiates
$450
BuyInitiates$450+16,323.36%Mar 27, 2023
Wells Fargo
Wells Fargo
Buy
Initiates
$450
BuyInitiates$450+16,323.36%Oct 4, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
568.06M
from 10.00K
Increased by 5,680,500.00%
Revenue Next Year
n/a
from 568.06M
EPS This Year
0.88
from -2.92
EPS Next Year
-0.14
from 0.88
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-398.00K2.92M5.00K10.00K568.06M-
Revenue Growth
--634.17%-99.83%100.00%5,680,500.00%-
EPS
-57.22-55.10-26.10-21.97-2.920.88-0.14
EPS Growth
-------
Forward PE
-----3.12-
No. Analysts
-----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
High584.8Mn/a
Avg568.1Mn/a
Low545.8Mn/a

Revenue Growth

Revenue Growth20252026
High
5,847,600.0%
-
Avg
5,680,500.0%
-
Low
5,457,800.0%
-

EPS Forecast

EPS20252026
High0.90-0.15
Avg0.88-0.14
Low0.84-0.14

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.